Abstract
Rheumatoid arthritis (RA) patients have increased mortality largely as a result of cardiovascular diseases (CVD) that cannot be explained by traditional risk factors, suggesting that systemic inflammation may accelerate atherosclerosis. We investigated the presence of subclinical atherosclerosis in early RA (<12 months) and the possible association of RA-related risk factors. Forty patients with early RA and 40 controls matched for age, sex, and traditional risk factors for CVD were selected. Carotid US examination, assay of lipogram, C-reactive protein (CRP), and oxidized low-density lipoprotein antibodies (OxLDL-ab) were done. RA patients had significantly higher carotid intima-media thickness (cIMT) values and more plaque than the control (P < 0.001 and P = 0.0122, respectively). CRP and OxLDL-ab were significantly higher in RA patients than controls. Traditional risk factors and RA-related risk factors (disease duration, DAS-28, duration of treatment with steroids, erythrocyte sedimentation rate, and CRP) as well as OxLDL and cIMT were significantly higher in RA with plaques compared to those without plaques. Regression analysis identified the age of patients, CRP, and OxLDL-ab as an independent risk factor associated with the presence of atherosclerosis. Conclusion: there is increased prevalence of carotid plaques in patients with recent-onset RA compared to matched controls. The accelerated atherosclerosis is predicted by age, CRP, and oxLDL-ab. The association of plaques with elevated CRP and OxLDL-ab support the hypothesis that chronic systemic autoimmune inflammatory process is probably a driving force for premature atherosclerosis.
Similar content being viewed by others
References
Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37:481–494
Troelsen LN, Jacobsen S (2006) Chronic inflammation increases the risk of cardiovascular disease in patients with rheumatoid arthritis. Ugeskr Laeger 168:3304–3308
Turesson C, Matteson EL (2007) Cardiovascular risk factors, fitness and physical activity in rheumatic diseases. Curr Opin Rheumatol 19:190–196
Peters MJ, van Halm VP, Nurmohamed MT, Damoiseaux J, Tervaert JW, Twisk JW et al (2008) Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis. J Rheumatol 35(8):1495–1499
Witztum JL, Steinberg D (1991) Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest Dec 88(6):1785–1792
Carroll L, Hannawi S, Marwick T, Thomas R (2006) Rheumatoid arthritis: links with cardiovascular disease and the receptor for advanced glycation end products. Wien Med Wochenschr 156:42–52
Lourida ES, Georgiadis AN, Papavasiliou EC, Papathanasiou AI, Drosos AA, Tselepis AD (2007) Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2. Arthritis Res Ther 9(1):R19
Salonen JT, Salonen R (1993) Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 87:II56–II65
Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ (2005) Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 52:2293–2299
Kumeda Y, Inaba M, Goto H, Nagata M, Henmi Y, Furumitsu Y, Ishimura E, Inui K, Yutani Y, Miki T et al (2002) Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 46:1489–1497
Arnett FC, Edworthy SM, Bloch DA, McShawe DJ, Fries JF, Cooper NS (1988) The American Rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Rheum 31(3):315–324
Bruce B, Fries JF (2003) The stanford health assessment questionnaire: a review of its history, issues, progress and documentation. J Rheumatol 30(1):167–178
van der Heijde DM, van’t Hof MA, van Riel PL, van Leeuwen MA, van Rijswijk MH, van de Putte LB (1992) Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis 51:177–181
Friedewald WT, Levy RI, Fredrickson D (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502
Fischer CL, Gill C, Forrester MG, Nakamura R (1976) Quantitation of “acute-phase proteins” postoperatively. Value in detection and monitoring of complications. Am J Clin Pathol 66(5):840–846
Damoiseaux J, Jeyasekharan AD, Theunissen R, Tervaert JW (2005) Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins. Ann N Y Acad Sci 1050:163–169
Borhani NO, Mercuri M, Borhani PA, Buckalew VM, Canossa M, Carr AA et al (1996) Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA 276(10):785–791
Joakimsen O, Bonaa KH, Stensland Bugge E (1997) Reproducibility of ultrasound assessment of carotid plaque occurrence, thickness and morphology. The Tromso Study. Stroke 28(11):2201–2207
Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115:459–467
Roman MJ, Moeller E, Davis A, Paget SA, Crow MK, Lockshin MD et al (2006) Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 144(4):249–256
Abu-Shakra M, Polychuck I, Szendro G et al (2005) Duplex study of the carotid and femoral arteries of patients with rheumatoid arthritis a controlled study. Semin Arthritis Rheum 35:18–23
Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108(24):2957–2963
Jonsson SW, Backman C, Johnson O et al (2001) Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 28:2597–2602
Steiner G, Urowitz MB (2009) Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 38(5):372–381
Pahor A, Hojs R, Gorenjak M, Rozman B (2006) Accelerated atherosclerosis in premenopausal female patients with rheumatoid arthritis. Rheumatol Int 27:119–123
Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732
Del Rincón I, Williams K, Stern MP et al (2003) Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 48:1833–1840
Willerson JT, Ridker PM (2004) Inflammation as a cardiovascular risk factor. Circulation 109:II2–II10
Nagata-Sakurai M, Inaba M, Goto H, Kumeda Y, Furumitsu Y, Inui K, Koyama H, Emoto M, Ishimura E, Shoji T et al (2003) Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum 48:3061–3067
Van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ES, Tak PP (2008) Systemic inflammation as a risk factor for atherothrombosis. Rheumatol (Oxford) 47(1):3–7
Salmon JE, Roman MJ (2008) Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 121(10 Suppl 1):S3–S8
Sakkinen P, Abbott RD, Curb JD, Rodriguez BL, Yano K, Tracy RP (2002) C-reactive protein and myocardial infarction. J Clin Epidemiol 55(5):445–451
Hannawi S, Haluska B, Marwick TH, Thomas R (2007) Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther 9(6):R116
Mayr M, Kiechl S, Tsimikas S, Miller E, Sheldon J, Willeit J et al (2006) Oxidized low-density lipoprotein autoantibodies, chronic infections and carotid atherosclerosis in a population-based study. J Am Coll Cardiol 47(12)):2436–2443
Jacobsson LTH, Knowler WC, Pillemer S, Hanson RL, Pettitt DJ, Nelson RG, Del Puente A, McCance DR, Charles M-A, Bennett PH (1993) Rheumatoid arthritis and mortality: a longitudinal study in Pima Indians. Arthritis Rheum 36:1045–1053
Submission declaration
The manuscript has not been published elsewhere and has not been submitted simultaneously for publication elsewhere.
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmed, H.M.M.S., Youssef, M. & Mosaad, Y.M. Antibodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis. Clin Rheumatol 29, 1237–1243 (2010). https://doi.org/10.1007/s10067-010-1436-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-010-1436-0